Meldonium (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Meldonium" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

799^th place

22^nd place

2^nd place

7^th place

1mayoclinic.org

1,610^th place

3,832^nd place

229^th place

398^th place

1theguardian.com

12^th place

32^nd place

28^th place

84^th place

1farmagalenica.it

low place

low place

1wada-main-prod.s3.amazonaws.com

low place

low place

as.com

en.as.com

(EN) WADA: 123 failed meldonium tests since January ban, su en.as.com.

cnn.com

(EN) Ford Vox, Sharapova suspension: doping agency's unfair game of 'gotcha'?, CNN. URL consultato il 14 marzo 2016.

doi.org

dx.doi.org

(EN) Y Zhu, G Zhang, J Zhao, D Li, X Yan, J Liu e altri, Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial., in Clinical Drug Investigation, ottobre 2013, DOI:10.1007/s40261-013-0121-x, PMID 23949899.
(EN) L Zvejniece, B Svalbe, M Makrecka, E Liepinsh, I Kalvinsh e M Dambrova, Mildronate exerts acute anticonvulsant and antihypnotic effects, in Behavioral Pharmacology, 2010, DOI:10.1097/FBP.0b013e32833d5a59.

farmagalenica.it

Marco Ternelli, Meldonium in Italia (mildronato): farmaco galenico in Farmacia, Farmagalenica, 6 aprile 2017.

mayoclinic.org

(EN) Myocardial ischemia, su mayoclinic.org, Mayo Clinic, 25 luglio 2015). URL consultato il 28 maggio 2016.

nih.gov

ncbi.nlm.nih.gov

(EN) N Sjakste, A Gutcaits e I Kalvinsh, Mildronate: an antiischemic drug for neurological indications., in CNS drug reviews, vol. 11, n. 2, 2004, pp. 151–68, PMID 16007237.
(EN) M Dambrova, M Makrecka-Kuka, R Vilskersts, E Makarova, J Kuka e E Liepinsh, Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity., in Pharmacological research, 2 febbraio 2016, PMID 26850121.
(EN) Y Zhu, G Zhang, J Zhao, D Li, X Yan, J Liu e altri, Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial., in Clinical Drug Investigation, ottobre 2013, DOI:10.1007/s40261-013-0121-x, PMID 23949899.

oadoi.org

(EN) Y Zhu, G Zhang, J Zhao, D Li, X Yan, J Liu e altri, Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial., in Clinical Drug Investigation, ottobre 2013, DOI:10.1007/s40261-013-0121-x, PMID 23949899.
(EN) L Zvejniece, B Svalbe, M Makrecka, E Liepinsh, I Kalvinsh e M Dambrova, Mildronate exerts acute anticonvulsant and antihypnotic effects, in Behavioral Pharmacology, 2010, DOI:10.1097/FBP.0b013e32833d5a59.

theguardian.com

amp.theguardian.com

(EN) Simon Cambers, Why was Maria Sharapova taking meldonium? Her lawyer responds, Londra, The Guardian, 10 marzo 2016.

wada-main-prod.s3.amazonaws.com

(EN) World Anti-Doping Agency, Prohibited List - January 2016 (PDF), su wada-main-prod.s3.amazonaws.com. URL consultato l'8 marzo 2016.